New Medication Available for People Who Have Moderate to Severe COPD
Recently, a brand new medication was approved for use in the United States by the Food & Drug Administration (FDA, for short). The drug's chemical name is Roflumilast, but is being marketed under the name Daliresp by New York City-based Forest Laboratories. It is specifically designed for people with severe COPD associated with chronic... Read more
